Last reviewed · How we verify
SPECIAL INVESTIGATION OF PREGABALIN FOR FIBROMYALGIA
To collect the efficacy and safety information of Pregabalin on Fibromyalgia patients related to their appropriate use in daily practice.
Details
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
|---|---|
| Status | COMPLETED |
| Enrolment | 534 |
| Start date | 2013-02 |
| Completion | 2017-07 |
Conditions
- Pain Associated With Fibromyalgia
Interventions
- Pregabalin
Primary outcomes
- Percentage of Participants With Adverse Drug Reaction — From Week 1 to 52 weeks at maximum
An adverse drug reaction (ADR) was any untoward medical occurrence attributed to LYRICA Capsules in a participant who received LYRICA Capsules. Relatedness to LYRICA Capsules was assessed by the physician.